bactenecin has been researched along with amprenavir in 1 studies
| Studies (bactenecin) | Trials (bactenecin) | Recent Studies (post-2010) (bactenecin) | Studies (amprenavir) | Trials (amprenavir) | Recent Studies (post-2010) (amprenavir) |
|---|---|---|---|---|---|
| 78 | 0 | 27 | 555 | 91 | 94 |
| Protein | Taxonomy | bactenecin (IC50) | amprenavir (IC50) |
|---|---|---|---|
| Gag-Pol polyprotein | Human immunodeficiency virus type 1 (BRU ISOLATE) | 0.027 | |
| Gag-Pol polyprotein | Human immunodeficiency virus type 2 (ISOLATE ROD) | 0.0026 | |
| Gag polyprotein | HIV-1 M:B_MN | 0.013 | |
| Cytochrome P450 3A4 | Homo sapiens (human) | 1 | |
| Gag-Pol polyprotein | Human immunodeficiency virus type 1 (NEW YORK-5 ISOLATE) | 0.0558 | |
| Thromboxane-A synthase | Homo sapiens (human) | 6.727 | |
| Protease | Human immunodeficiency virus 1 | 0.1553 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ganapathi, U; Gunaseelan, S; Myers, DR; Nelson, AG; Palombo, MS; Samizadeh, M; Singh, Y; Sinko, PJ; Szekely, Z; Zhang, X | 1 |
1 other study(ies) available for bactenecin and amprenavir
| Article | Year |
|---|---|
Colorectal delivery and retention of PEG-Amprenavir-Bac7 nanoconjugates--proof of concept for HIV mucosal pre-exposure prophylaxis.
Topics: Administration, Rectal; Animals; Caco-2 Cells; Carbamates; Cell-Penetrating Peptides; Furans; HIV Infections; HIV Protease; HIV Protease Inhibitors; HIV-1; Humans; Intestinal Mucosa; Male; Mice; Mice, Inbred Strains; Nanoconjugates; Peptides, Cyclic; Polyethylene Glycols; Pre-Exposure Prophylaxis; Sulfonamides | 2016 |